Literature DB >> 8656606

Increased proliferation in keloid fibroblasts wounded in vitro.

M Calderon1, W T Lawrence, A J Banes.   

Abstract

A keloid is a pathological overgrowth of scar expanding beyond the boundaries of the initiating skin wound. Ultimately, this expansive scar is a result of excess collagen synthesized by fibroblasts within the wound. The processes that lead to this collagen excess remain unknown. An in vitro wound model was developed to test the hypothesis that fibroblasts isolated from keloid tissue and wounded in vitro might proliferate more rapidly that similarly wounded normal dermal fibroblasts. Keloid fibroblasts (KF) and normal human dermal fibroblasts (NDF) were grown to confluence and quiescence in flexible-bottomed culture plates. Wounds were created in a standardized fashion using a specially designed jig. The jig utilized a 25 gauge needle to reproducibly ablate 16-20% of cells from confluent cell sheets. Wounded and nonwounded cells were labeled with 3H-thymidine at 24, 48, 72 and 96 hr postwounding to measure DNA synthesis. Wounded KF and NDF demonstrated increased 3H-thymidine incorporation compared to nonwounded control cultures, and wounded KF demonstrated significantly higher levels of 3H-thymidine incorporation than wounded NDF both 24 and 48 hr after wounding. A similar trend was seen in cell counts. The wounded KF also showed a statistically greater labeling index quantitated by autoradiography than did wounded NDF. The increased commitment to DNA synthesis in response to wounding in vitro in keloid fibroblasts correlates with pathology seen in vivo. Keloid fibroblasts may have a lower inherent threshold for S phase entry than do normal fibroblasts contributing to the increased proliferation of keloid fibroblasts in response to wounding in vitro.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8656606     DOI: 10.1006/jsre.1996.0127

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  19 in total

Review 1.  Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring.

Authors:  Peter Adam Rees; Nicholas Stuart Greaves; Mohamed Baguneid; Ardeshir Bayat
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

2.  RUNX3 expression is associated with sensitivity to pheophorbide a-based photodynamic therapy in keloids.

Authors:  Zhenlong Zheng; Lianhua Zhu; Xianglan Zhang; Lianhua Li; Sook Moon; Mi Ryung Roh; Zhehu Jin
Journal:  Lasers Med Sci       Date:  2014-06-24       Impact factor: 3.161

3.  Apoptosis, necrosis, and proliferation: possible implications in the etiology of keloids.

Authors:  I Appleton; N J Brown; D A Willoughby
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 4.  Tracing skin aging process: a mini- review of in vitro approaches.

Authors:  Sophia Letsiou
Journal:  Biogerontology       Date:  2021-03-15       Impact factor: 4.277

5.  Effect of collagen nanotopography on keloid fibroblast proliferation and matrix synthesis: implications for dermal wound healing.

Authors:  Lalitha Muthusubramaniam; Tatiana Zaitseva; Michael Paukshto; George Martin; Tejal Desai
Journal:  Tissue Eng Part A       Date:  2014-05-20       Impact factor: 3.845

6.  Long non-coding RNA H19 promotes the proliferation of fibroblasts in keloid scarring.

Authors:  Jie Zhang; Cai Yue Liu; Yun Wan; Li Peng; Wen Fang Li; Jia Xuan Qiu
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

7.  Aquaporin-3 facilitates epidermal cell migration and proliferation during wound healing.

Authors:  Mariko Hara-Chikuma; A S Verkman
Journal:  J Mol Med (Berl)       Date:  2007-10-30       Impact factor: 4.599

Review 8.  Redox control of the cell cycle in health and disease.

Authors:  Ehab H Sarsour; Maneesh G Kumar; Leena Chaudhuri; Amanda L Kalen; Prabhat C Goswami
Journal:  Antioxid Redox Signal       Date:  2009-12       Impact factor: 8.401

9.  A human full-skin culture system for interventional studies.

Authors:  Lars Steinstraesser; Andrea Rittig; Kai Gevers; Michael Sorkin; Tobias Hirsch; Marco Kesting; Michael Sand; Sammy Al-Benna; Stefan Langer; Hans-Ulrich Steinau; Frank Jacobsen
Journal:  Eplasty       Date:  2009-01-09

10.  A novel human skin chamber model to study wound infection ex vivo.

Authors:  Lars Steinstraesser; M Sorkin; A D Niederbichler; M Becerikli; J Stupka; A Daigeler; M R Kesting; I Stricker; F Jacobsen; M Schulte
Journal:  Arch Dermatol Res       Date:  2009-12-03       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.